---
title: "Verapamil - Atrial fibrillation"
sidebar: mydoc_sidebar
permalink: db00661-mesh-d001281-1.html
toc: false 
---


Path ID: `DB00661_MESH_D001281_1`
{% include image.html url="images/db00661-mesh-d001281-1.png" file="db00661-mesh-d001281-1.png" alt="db00661-mesh-d001281-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014700 | verapamil | Drug |
| MESH:D020746 | Calcium Channels, L-Type | GeneFamily |
| GO:0061337 | cardiac conduction | BiologicalProcess |
| MESH:D006339 | Heart Rate | BiologicalProcess |
| HP:0001692 | Atrial arrhythmia | PhenotypicFeature |
| MESH:D001281 | Atrial fibrillation | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Verapamil | DECREASES ACTIVITY OF | Calcium Channels, L-Type |
| Calcium Channels, L-Type | POSITIVELY REGULATES | Cardiac Conduction |
| Cardiac Conduction | POSITIVELY CORRELATED WITH | Heart Rate |
| Heart Rate | POSITIVELY CORRELATED WITH | Atrial Arrhythmia |
| Atrial Arrhythmia | MANIFESTATION OF | Atrial Fibrillation |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00661#mechanism-of-action](https://go.drugbank.com/drugs/DB00661#mechanism-of-action){:target="_blank"}